ApoB goal optimal in 65% of probabilistic analyses at willingness-to-pay threshold of $120,000 per QALY gained.
Modern medicine is improving in precision, identifying exactly who needs treatment and who doesn’t. In heart disease ...
initial and final assessment of both TC and HDL-C, so that non-HDL-C could be calculated. A coding sheet was developed that could hold more than 200 items per study. The major categories of items ...
Clin Lipidology. 2013;8(1):69-79. The decision about whether to use a new biomarker depends upon how readily it is measured, its potential to add new information and its ability to aid the clinician ...
Patients with persistent non-high-density lipoprotein (HDL) cholesterol dyslipidemia from childhood to adulthood had an increased risk of cardiovascular disease (CVD) events, but those who had ...
A routine blood test taken by millions in the U.S. each year to measure "bad" cholesterol is not the best measure to guide ...
Researchers in medicine have been studying the composition of biochemical markers to determine correlations between during health and disease for several decades. The data helps healthcare ...
Elevated NHHR is linked to a 7% increased risk of psoriasis per unit increase, with a 39% higher risk in the highest NHHR tertile. The study's findings were consistent across subgroups, reinforcing ...
Numerous methods have been developed to quantify the levels of pro- and anti-atherogenic lipoproteins in the blood. Lipoproteins measured by many, but not all, of the assays have been shown to be ...
CORALreef Lipids randomized 2,909 adults (2:1) to enlicitide 20 mg daily or placebo across 168 sites, using stratification by renal function, baseline statin use, and region. LDL-C at week 24 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results